Careers  |  Sign In  |  Register  |   Twitter

Latest in Reuters Health News

By Ben Hirschler LONDON (Reuters) – British drugmaker Shire’s dry eye drug lifitegrast reduced patient-reported symptoms of eye dryness in a late-stage trial – the first drug to do so in a phase III setting – but it missed a second target that measured signs of the disease based on...
By Will Boggs, MD   NEW YORK (Reuters Health) – Reoperation rates after resident-performed cataract surgery hover around 2%, researchers say. “Reoperations after cataract surgery have implications for visual prognosis and overall healthcare costs,” Dr. Shivali A. Menda from University of...
By Will Boggs, MD NEW YORK (Reuters Health) – Adenoidectomy performed at the time of initial tympanostomy tube placement (TT) may reduce the risk of repeat surgery for otitis media and other adverse outcomes, according to a new meta-analysis. Previous studies have demonstrated the benefits of...